NasdaqCM - Nasdaq Real Time Price USD

Liquidia Corporation (LQDA)

Compare

11.10

+0.51

(+4.82%)

At close: December 20 at 4:00:02 PM EST

10.50

-0.60

(-5.41%)

After hours: December 20 at 6:44:26 PM EST

December 2024 US Growth Stocks With Strong Insider Ownership

As December 2024 unfolds, the U.S. stock market is experiencing notable volatility, with the Dow Jones Industrial Average marking its longest losing streak since 1978 amid anticipation of a Federal Reserve interest rate decision. Despite these fluctuations, growth companies with substantial insider ownership continue to capture investor interest due to their potential for aligned management interests and long-term value creation in uncertain economic environments.

Simply Wall St. 4 days ago

PAY

RCAT

LQDA
+4.82%
Here’s Arquitos Capital Management’s Updates on Liquidia (LQDA)

Arquitos Capital Management, an investment management firm, released its third quarter 2024 investor letter. A copy of the letter can be downloaded here. The strategy returned -15.5% in the third quarter of 2024, bringing the year-to-date return to 4.5%. This year has witnessed quite a bit of volatility as usual. Prior to the decline this […]

Insider Monkey 9 days ago

LQDA
+4.82%
Does Liquidia Technologies (LQDA) Have the Potential to Rally 132.54% as Wall Street Analysts Expect?

The mean of analysts' price targets for Liquidia Technologies (LQDA) points to a 132.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks 9 days ago

LQDA
+4.82%
Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High?

The consensus price target hints at a 126.1% upside potential for Liquidia Technologies (LQDA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks 25 days ago

LQDA
+4.82%
3 US Growth Stocks With At Least 10% Insider Ownership

As geopolitical tensions rise, the U.S. stock market has experienced early declines, with major indices such as the Dow Jones Industrial Average and S&P 500 slipping amid investor concerns. In this environment of uncertainty, stocks with substantial insider ownership can offer a unique perspective on potential growth opportunities, as insiders may have confidence in their company's long-term prospects despite short-term market fluctuations.

Simply Wall St. last month

LQDA
+4.82%
AEYE

GHLD
Liquidia Third Quarter 2024 Earnings: Beats Expectations

Liquidia ( NASDAQ:LQDA ) Third Quarter 2024 Results Key Financial Results Revenue: US$4.45m (up 21% from 3Q 2023). Net...

Simply Wall St. last month

LQDA
+4.82%
Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...

Liquidia Corp (LQDA) outlines promising clinical progress and strategic partnerships while navigating regulatory and financial hurdles.

GuruFocus.com last month

LQDA
+4.82%
Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates

Liquidia Technologies (LQDA) delivered earnings and revenue surprises of 0% and 0.75%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

LQDA
+4.82%
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Received tentative approval from the FDA for YUTREPIA™ (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD)U.S. Supreme Court rejected final appeal of ‘793 patent decision, marking victories with respect to three patents originally asserted final and not subject to further appealStrengthened balance sheet by raising approximately $100 million in additional capital MORRISVILLE, N.C., Nov. 13,

GlobeNewswire last month

LQDA
+4.82%
Liquidia to Present at the Stifel 2024 Healthcare Conference

MORRISVILLE, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present at the Stifel 2024 Healthcare Conference in New York City on Tuesday, November 19, 2024, from 3:00 – 3:30 p.m. ET. Access to the live webcasts will be available to investors and other interested parties via Liquidia’s website at https://liquidia.com/invest

GlobeNewswire last month

LQDA
+4.82%
Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?

Arcellx (ACLX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks last month

ACLX

LQDA
+4.82%
Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years

When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...

Simply Wall St. last month

LQDA
+4.82%
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024

MORRISVILLE, N.C., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today it will now report its third quarter 2024 financial results on Wednesday, November 13, 2024. The date has been moved to accommodate for SEC filing rules impacted by the federal holiday observed on Monday, November 11, 2024. The company will host a live webcast at 8:30 a.m. Eastern Time

GlobeNewswire last month

LQDA
+4.82%
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024

MORRISVILLE, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its third quarter 2024 financial results on Monday, November 11, 2024. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update. The live webcast will be available on Liquidia's website at https:/

GlobeNewswire last month

LQDA
+4.82%
Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know

YmAbs Therapeutics (YMAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks last month

YMAB
-3.38%
LQDA
+4.82%
Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Liquidia Technologies (LQDA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks last month

LQDA
+4.82%
CSTL
3 US Growth Stocks With High Insider Ownership And Earnings Growth Up To 61%

As the U.S. stock market continues to reach new heights, driven by strong performances in sectors like semiconductors and artificial intelligence, investors are increasingly focused on growth opportunities with robust fundamentals. In this environment, companies with high insider ownership and significant earnings growth potential can be particularly attractive, as they often indicate strong alignment between management and shareholder interests.

Simply Wall St. 2 months ago

LQDA
+4.82%
TOST

GCT
Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ...

Despite a drop in revenue, Liquidia Corp (LQDA) remains optimistic with strong cash reserves and promising developments in its YUTREPIA program.

GuruFocus.com 2 months ago

LQDA
+4.82%
Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?

Liquidia Technologies (LQDA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks 2 months ago

LQDA
+4.82%
SCPH
+2.42%
Liquidia Shares Jump After US Supreme Court Rejects United Therapeutics' Appeal in Patent Dispute

Liquidia Shares Jump After US Supreme Court Rejects United Therapeutics' Appeal in Patent Dispute

PREMIUM
MT Newswires 2 months ago

LQDA
+4.82%
UTHR

Performance Overview

Return	LQDA	S&P 500
YTD	-7.73%	+24.34%
1-Year	+40.68%	+24.38%
3-Year	+168.12%	+28.36%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Liquidia Corporation (LQDA)

December 2024 US Growth Stocks With Strong Insider Ownership

Here’s Arquitos Capital Management’s Updates on Liquidia (LQDA)

Does Liquidia Technologies (LQDA) Have the Potential to Rally 132.54% as Wall Street Analysts Expect?

Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High?

3 US Growth Stocks With At Least 10% Insider Ownership

Liquidia Third Quarter 2024 Earnings: Beats Expectations

Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...

Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Liquidia to Present at the Stifel 2024 Healthcare Conference

Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?

Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024

Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know

Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

3 US Growth Stocks With High Insider Ownership And Earnings Growth Up To 61%

Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ...

Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?

Liquidia Shares Jump After US Supreme Court Rejects United Therapeutics' Appeal in Patent Dispute

Performance Overview